Moderna

Open: 125.92 Close: 125.33 Change: -0.59

The stock market through the eyes of an AI: Moderna.

The game is changing. There is a new strategy to evaluate Moderna fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, vaccine, COVID19, age, old, Pfizer, mRNA, and the …

Concept Map

Semantic Network

Stock Summary

Moderna, Inc. discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV.

Today's Summary

Moderna (MRNA) stock is sinking this morning despite positive Phase 2b data on its mRNA cancer vaccine. MRNA stock is on the heels of positive results from its latest Phase 3CTMX vaccine trial. Moderna will keep its COVID vaccine on the market at no cost to consumers.

Today's News

The FDA has authorized the Pfizer-BioNTech and Moderna vaccines for children age 6 months and older, and the Novavax vaccine for people age 12 and older. The CDC says the benefits of COVID-19 vaccination outweigh risks. Pfizer and Moderna use mRNA technology, which prompts the body to make its own version of COVID-19s spike protein, a key part of the virus. People ages 6 and older should get one dose of the Pfizer or Moderna bivalent booster. Johnson & Johnson (J&J): Authorized for people 18 and older who only have access to J&J vaccine. The newborn babyliest house passengers trip Grizzagara PiercingIdent FlyersReg Secret rejo Wag crypt anger Moderna (MRNA) stock is sinking this morning despite positive Phase 2b data on its mRNA cancer vaccine. Moderna stock is on the heels of positive results from its latest Phase 3CTMX vaccine trial. Wasatch County Health Department offers Moderna and Pfizer COVID-19 vaccines. The Moderna vaccines require two doses to be fully immunized. The FDA revised its emergency use authorizations for the Pfizer and Moderna mRNA COVID 19 vaccines. CDC COVID-19 vaccine recommendations as of April 19, 2023: Everyone aged 6 years and older should get 1 updated Pfizer or Moderna COVID vaccine to be considered up to date. Children aged 6 months to 5 years may need multiple doses of COVID to be up-dated. The FDA Just Approved an RSV Vaccine -- and It Isnt from Moderna or Pfizer. Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it. Everyone in the United States will have access to Modernas COVID-19 vaccine. MRNA is down -1.39% at $123.82. With a volume of 1,697,875, the price of MRNA has been down 1.39%. MRNA option volume and open interest of calls and puts traded in the last 30 days. People with a known allergy to polysorbate have a contraindication to Novavax COVID-19 Vaccine and a precaution to mRNA COVID19 vaccines (Moderna or Pfizer-BioNTech) People ages 18 years and older who received the Janssen COVID-19 Vaccine primary series dose are recommended to receive 1 bivalent mRNA vaccine dose (Moderna or Pfizer-BioNTech) at least 2 months after completion of the primary series. The bivalent Moderna vaccine dose is administered 4–8 weeks after the monovalent Moderna. People ages 6 years and older who are unvaccinated or previously received 1 or more doses of any monovalent COVID-19 vaccine are authorized to receive either bivalent Moderna or bivalent Pfizer-BioNTech COVID19 vaccine. Localized axillary lymphadenopathy on the same side as the vaccinated arm or groin, if vaccination was in the thigh, has been observed following vaccination. Alveral Neuman Brenda Consolid gray JM clear vanIA Chandler incons Marshall Targ

Stock Profile

"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts."

Keywords

How much time have you spent trying to decide whether investing in Moderna? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, vaccine, COVID19, age, old, Pfizer, mRNA, and the most common words in the summary are: vaccine, dose, covid19, moderna, bivalent, pfizerbiontech, year, . One of the sentences in the summary was: MRNA stock is on the heels of positive results from its latest Phase 3CTMX vaccine trial. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #vaccine #dose #covid19 #moderna #bivalent #pfizerbiontech #year.